Two Sigma Investments
ONCT

Two Sigma Investments’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History

Two Sigma Investments’s Portfolio ONCT Stock Details ONCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,734
Closed -$40K – 3507
2023
Q4 		$40K Hold
3,734
– – ﹤0.01% 3010
2023
Q3 		$22.4K Sell
3,734
-340
-8% -$2.39K ﹤0.01% 2865
2023
Q2 		$28.1K Hold
4,074
– – ﹤0.01% 2884
2023
Q1 		$64K Sell
4,074
-4,678
-53% -$92.1K ﹤0.01% 2721
2022
Q4 		$175K Sell
8,752
-9,060
-51% -$180K ﹤0.01% 2422
2022
Q3 		$318K Buy
17,812
+10,265
+136% +$220K ﹤0.01% 1955
2022
Q2 		$168K Sell
7,547
-2,004
-21% -$44.7K ﹤0.01% 2198
2022
Q1 		$266K Buy
9,551
+2,758
+41% +$100K ﹤0.01% 2253
2021
Q4 		$308K Sell
6,793
-15,831
-70% -$1.07M ﹤0.01% 3634
2021
Q3 		$1.89M Sell
22,624
-5,013
-18% -$415K ﹤0.01% 2049
2021
Q2 		$2.63M Buy
27,637
+22,089
+398% +$2.62M 0.01% 1657
2021
Q1 		$923K Sell
5,548
-3,707
-40% -$490K ﹤0.01% 2396
2020
Q4 		$907K Buy
+9,255
New +$586K ﹤0.01% 2077
2019
Q1 		– Sell
-938
Closed -$102K – 3562
2018
Q4 		$102K Buy
938
+193
+26% +$38.6K ﹤0.01% 2809
2018
Q3 		$164K Buy
+745
New +$1.79M ﹤0.01% 3039
2014
Q1 		– Sell
-8
Closed -$19K – 2324
2013
Q4 		$19K Buy
+8
New +$18.3K ﹤0.01% 2141

Other funds holding ONCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
QPW
Quantum Private Wealth Tampa, Florida $390M AUM 58.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $2.37B AUM 16.36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Investments's ONCT Position: Q1 2024 in Review

Two Sigma Investments sold out of Oncternal Therapeutics, Inc. Common Stock (ONCT) in Q1 2024, closing a stake of 3,734 shares — an estimated $40K sold.

Two Sigma Investments first reported a position in ONCT in Q4 2013 and held it in 16 quarters. The position peaked at $2.63M in Q2 2021. 24 funds tracked by Wall St. Rank hold ONCT as of Q1 2024.

  • Two Sigma Investments reported no remaining Oncternal Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Two Sigma Investments sold 3,734 Oncternal Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $40K.
  • Two Sigma Investments first reported a position in Oncternal Therapeutics, Inc. Common Stock in Q4 2013 and held it in 16 quarters.
  • Two Sigma Investments's Oncternal Therapeutics, Inc. Common Stock position peaked at $2.63M in Q2 2021.
  • 24 funds tracked by Wall St. Rank held Oncternal Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.